For citations:
Kostinov M.P., Markelova E.V., Knysh S.V., Lee Yu.A., Khasanova A.A., Solovеva I.L., Korovkina E.S., Linok A.V., Lоktionova M.N., Khrapunova I.A., Kharseeva G.G. On the Possibility of Using the Topical form of the Recombinant Interferon alpha-2b Drug in the Prevention of Acute Respiratory Viral Infections in Organized Groups. Epidemiology and Vaccinal Prevention. 2024;23(2):87-93. (In Russ.) https://doi.org/10.31631/2073-3046-2024-23-2-87-93